Loading clinical trials...
Loading clinical trials...
Bioavailability of Alprazolam Tablets, 2 mg.
Conditions
Interventions
Alprazolam Tablets, 2 mg (Geneva Pharmaceuticals, Inc.)
Start Date
February 1, 1996
Primary Completion Date
February 1, 1996
Completion Date
February 1, 1996
Last Updated
March 28, 2017
NCT07478393
NCT07456631
NCT07444697
NCT07432945
NCT07168577
NCT07429617
Lead Sponsor
Sandoz
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions